You are here

Brian Daniels


Daniels BR, Rikhy R, Renz M, et al. Multiscale diffusion in the mitotic Drosophila melanogaster syncytial blastoderm. Proc Natl Acad Sci. 2012;109(22):8588-8593.

Daniels BR, Hale CM, Khatau SB, et al. Differences in the microrheology of human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) cells. Biophys J. 2010;99(11):3563-3570.

Daniels BR, Perkins EM, Dobrowsky TM, et al. Asymmetric enrichment of PIE-1 in the C. elegans zygote mediated by binary counter-diffusion. J Cell Biol. 2009;184(4):473-479.

Brian Daniels, Ph.D.

Brian Daniels serves as the associate director for the Broad Institute of MIT and Harvard’s Cardiovascular Disease Initiative (CVDi). In this role, Brian oversees all stages of CVDi’s therapeutic pipeline, including target identification, target validation, assay development, lead finding and optimization, and preclinical development. Brian manages CVDi’s industry alliances, principally our Broad–Bayer Collaboration in cardiovascular disease.

Before joining the Broad Institute in 2015, Daniels managed technology development partnerships aimed at improving the efficiency of drug discovery and development at a non-profit spinout from MIT. Daniels completed his postdoctoral training in the Cell Biology and Metabolism branch of the National Institutes of Health (NIH), where he applied advanced imaging techniques to study intracellular trafficking in the secretory pathway. His experience at NIH led him to become involved in public policy, and he was selected as an AAAS Science & Technology Policy Fellow in the area of global health security. In this role, Daniels managed interactions between several departments and agencies of the U.S. government, non-governmental organizations, and foreign governments with the goal of improving global disease detection, diagnosis, and reporting.

Brian received his Ph.D. in chemical & biomolecular engineering from the Johns Hopkins University, where his research was focused on cell-fate specification in stem cell populations and in developing embryos.

Contact Brian Daniels via email at

February 2018